Current and emerging therapies in MS
Dr Alasdair Coles
Neurologist and MS Researcher
Filmed at Addenbrooke's Hospital, Cambridge
20 August 2009
In the seven parts of this video, Dr Coles gives an overview on four current or emerging therapies for persons with multiple sclerosis (MS). These are Tysabri, Cladribine, Fingolimod and Alemtuzumab.
He discusses the importance of expert advice in the decision making process and the status on licensing, safety, effectiveness and convenience for each of these drugs.
Click on the player above to play the seven parts of the talk
He discusses the importance of expert advice in the decision making process and the status on licensing, safety, effectiveness and convenience for each of these drugs.
Click on the player above to play the seven parts of the talk
Playlist for this awareness talk
If you would prefer to watch any of parts of this film individually, you can click on any of the links below to head straight to the film on our YouTube channel:Download the transcript
If you would prefer to read the transcript of the talk, or download for further use, you can do so by clicking on the link above.Online question and answer session
Dr Coles answered questions relating to current and emerging therapies in MS from Monday 28 September to Sunday 4 October 2009 in one of our online question and answer sessions. Please use the link above to view the questions and answers.
Current and emerging therapies - transcript
Transcript of the video talk given by Dr Alasdair Coles on the subject of four current and emerging therapies for MS.
Transcript of the video talk given by Dr Alasdair Coles on the subject of four current and emerging therapies for MS.
